ArticleFrontiers in oncology2024

Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review.

Man Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.